Repligen Market Risk Adjusted Performance
| RGEN Stock | | | USD 117.52 0.00 0.00% |
Historical market data for Repligen forms the basis of the Market Risk Adjusted Performance indicator shown here. Related indicator context is organized within
Equity Screeners. Repligen has a market cap of 6.41 B, operating margin of 8.26%, ROE of 2.4%. Allocation context is available in
Your Equity Center. A position in Repligen is part of the allocation. It is reflected in the overall portfolio structure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in unemployment.
For more detail on how to invest in Repligen Stock please use our
How to Invest in Repligen Stock guide.
Repligen has current Market Risk Adjusted Performance of
-0.34.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.34 | |
| ER[a] | = | Expected return on investing in Repligen |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Repligen is rated
below average in market risk adjusted performance compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors .
Other Technical Indicators